Candriam Equities L Biotechnology Class R2 Unhedged Fonds
350,59
EUR
-0,39
EUR
-0,11
%
NAV
Werbung
sharpe ratio
| 1 year | 3 years | 5 years | |
|---|---|---|---|
| sharpe ratio | 0,97 | 0,70 | 0,59 |